Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
Takemura M, Motegi M, Kuroiwa Y, Itai M, Taguchi K, Umetsu K, Uchida M, Kounoc S, Sato M, Masubuchi H, Yamaguchi A, Yamaguchi K, Ikeda K, Nakagawa J, Maeno T.
Takemura M, et al. Among authors: nakagawa j.
Respir Med Case Rep. 2021 Feb 2;32:101361. doi: 10.1016/j.rmcr.2021.101361. eCollection 2021.
Respir Med Case Rep. 2021.
PMID: 33643837
Free PMC article.